Gang Bao, the Foyt Family Professor of Bioengineering, professor of chemistry and of materials science and nanoengineering, and CPRIT Scholar in Cancer Research at Rice University, has been named associate dean for research and innovation in the George R. Brown School of Engineering. The appointment was effective July 1.
“I’m thrilled to be working with Gang in this important role. He brings a wealth of expertise in engineering to the position. He has conducted research in a broad range of topics, including fatigue and fracture in composite materials, molecular biomechanics and bioengineering, nanomedicine and genome editing. He will bring a unique perspective to his new position,” said Reginald DesRoches, the William and Stephanie Sick Dean of Engineering.
Before joining the Rice faculty in 2015, Bao had 24 years of experience in research and education as a faculty member at Johns Hopkins University (1991-1999), and Georgia Tech and Emory University (1999-2015), where he was the Robert A. Milton Chair in the Wallace H. Coulter Department of Biomedical Engineering.
Bao established and managed three large research centers, including the National Institutes of Health (NIH) -funded Program of Excellence in Nanotechnology at Emory and Georgia Tech (2005-15, with funding exceeding $26.1 million), the NIH-funded Nanomedicine Development Center at Georgia Tech and Rice (2006-16, exceeding $24 million) and the Center for Pediatric Nanomedicine, funded by Children's Healthcare of Atlanta (2011-16, exceeding $5 million).
Working with colleagues at MIT, Georgia Tech and University of Illinois Urbana–Champaign, Bao was instrumental in establishing an NSF Science and Technology Center in 2010, and served as its co-PI and research director. Bao was also a co-PI of the NIH-funded Center of Cancer Nanotechnology Excellence at Emory (2005-10).
As a CPRIT (Cancer Prevention and Research Institute of Texas) Senior Scholar at Rice, Bao’s research focuses on the development of nanoengineering tools for diagnosing and treating cancer. Included are new multi-modality imaging probes, magnetic nanoparticles for cancer hyperthermia treatment, multi-functional nanoparticles for targeted drug/gene delivery, cell tracking and ultra-sensitive biomarker detection.
In recent years, Bao has been working on genome editing, including the development of tools for the design and optimization of CRISPR/Cas9 systems, evaluation of their on- and off-target effects, and establishment of clinically useful approaches for treating single-gene disorders, including sickle-cell disease.
Bao has filed 15 patent applications and is the author of almost 200 peer-reviewed journal articles. He is founder and president of iLISATech, Inc., a start-up focusing on commercializing nanoparticle-based protein quantitation technology. He was co-founder and CEO of Vivinetics, a start-up in Atlanta. Bao is a fellow of the Biomedical Engineering Society (2017), the American Association for the Advancement of Science (2009), the American Society of Mechanical Engineers (2009), the American Physical Society (2007) and the American Institute for Medical and Biological Engineering (2007).
Bao earned a B.S. in mechanical engineering and an M.S. in applied mechanics from Shandong University in China in 1976 and 1981, respectively, and a Ph.D. in applied mathematics from Lehigh University in 1987. From 1988 to 1991, he worked as a postdoctoral fellow in materials at the University of California, Santa Barbara.